Clozapine dosage, serum levels, efficacy, and side-effect profiles: A comparison of Korean-American and Caucasian patients

Psychopharmacology Bulletin

Volumn 32, Issue 2, 1996, Pages 253-257

  Matsuda, K Traci ^a,b,c   Cho, Man Chul ^a,c   Lin, Keh Ming ^a,b   Smith, Michael W ^a,b   Young, Alexander S ^a,d,e   Adams, Jeffrey A ^a,d  

^a HARBOR UCLA MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Asian Pac Counseling Treatm Ctr   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e Los Angeles Co/S Monica W M   (United States)

Author keywords

Asians; clozapine; dosage; serum level; side effects

Indexed keywords

CLOZAPINE;

ADULT; AGRANULOCYTOSIS; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; KOREA; MALE; PRIORITY JOURNAL; RATING SCALE; SCHIZOPHRENIA; UNITED STATES;

ADULT; ASIAN AMERICANS; CLOZAPINE; ETHNIC GROUPS; FEMALE; HUMANS; MALE; MIDDLE AGED;

EID: 9344235447     PISSN: 00485764     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. American Psychiatric Association. DSM-III-R: Diagnostic and Statistical Manual of Mental Disorders. 3d ed., revised. Washington, DC: The Association, 1987.
2. Amsler, HA; Teerenhovi, L; Barth, E; Harjula, K; and Vuopio, P. Agranulocytosis in patients treated with clozapine. A study of the Finnish epidemic. Acta Psychiatr. Scand. 56:241-248, 1977.
3. Chang, WH; Chien, CP; Lin, SK; and Chung, MK. Elevated clozapine concentrations in Chinese patients. Neuropsychopharmacology 9:1178, 1993.
4. Hasegawa, M; Gutierrez-Esteinou, R; Way, L; and Meltzer, HY. Relationship between clinical efficacy and clozapine concentrations in plasma in schizophrenia: Effect of smoking. J. Clin. Psychiatry 13:383-390, 1993.
5. Lieberman, J; Yunis, J; and Egea, E. HLA-B38, DR4, DQw3 and clozapine-induced argranulocytosis in Jewish patients with schizophrenia. Arch. Gen. Psychiatry 47:945-948, 1990.
6. Lin, K-M, and Poland, RE. Ethnicity, culture, and psychopharmacology. In: Bloom, FE, and Kupfer, DI, eds. Psychopharmacology: The Fourth Generation of Progress. New York: Raven Press, 1995. pp. 1907-1917.
7. Lin, K-M; Poland, RE; Lau, J; and Rubin, RT. Haloperidol and prolactin concentrations in Asians and Caucasians. J. Clin. Psychopharmacol. 8:195-201, 1988.
8. Lin, K-M; Poland, RE; Nuccio, I; Matsuda, K; Hathuc, N; Su, T; and Fu, P. Longitudinal assessment of haloperidol dosage and serum concentration in Asian and Caucasian schizophrenic patients. Am. J. Psychiatry 146:1307-1311, 1989.
9. Miller, DD; Fleming, F; Holman, TL; and Perry, PJ. Plasma clozapine concentrations as a predictor of clinical response: A follow-up study. J. Clin. Psychiatry 55(9) Suppl. B: 117-121, 1994.
10. Overall, J, and Gorham, D. The Brief Psychiatric Rating Scale. Psychol. Rep. 10:799-812, 1962.
11. Perry, PJ; Miller, DD; Arndt, SV; and Cadoret, RJ. Clozapine and norclozapine plasma concentrations and clinical response of treatment-refractory schizophrenic patients. Am. J. Psychiatry 148(2):231-235, 1991.
12. Pfister, G; Hanson, D; Roerig, J; Landbloom, R; and Popkin, M. Clozapine-induced agranulocytosis in a Native American: HLA typing and further support for an immune-medicated mechanism. J. Clin. Psychiatry 53:242-244, 1992.
13. Potkin, SG; Bera, R; Gulasekaram, B; Costa, J; Hayes, S; Jin, Y; Richmond, G; Carreon, D; Sitanggan, K; and Gerber, B. Plasma clozapine concentrations predict clinical response in treatment-resistant schizophrenia. J. Clin. Psychiatry 55(9) Suppl. B: 133-136, 1994.
14. Potter, WZ; Ko, GN; Zhang, LD; and Yan, WW. Clozapine in China: A review and preview of US/PRC collaboration. Psychopharmacology (Berlin) 99 (Suppl.):S87-91, 1989.
15. Rhoades, HM, and Overall, JE. The semistructured BPRS interview and rating guide. Psychopharmacol. Bull. 24:101-104, 1988.